UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 271

Sortiert nach

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Journal of clinical oncology, 2012-10, Vol.30 (29), p.3633-3639

2012

Link zum Volltext

Verfügbarkeit prüfen

Mutant p53 reactivation by small molecules makes its way to the clinic

FEBS letters, 2014-08, Vol.588 (16), p.2622-2627

2014

Link zum Volltext

Verfügbarkeit prüfen

APR-246 reactivates mutant p53 by targeting cysteines 124 and 277

Cell death & disease, 2018-04, Vol.9 (5), p.439-12, Article 439

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy

Frontiers in oncology, 2016-02, Vol.6, p.21-21

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene

PloS one, 2023-11, Vol.18 (11), p.e0292468-e0292468

2023

Link zum Volltext

Verfügbarkeit prüfen

The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer

Biochemical and biophysical research communications, 2010-05, Vol.396 (1), p.85-89

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246

Scientific reports, 2018-08, Vol.8 (1), p.12671-10, Article 12671

2018

Link zum Volltext

Verfügbarkeit prüfen

PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain

Cancer cell, 2009-05, Vol.15 (5), p.376-388

2009

Link zum Volltext

Verfügbarkeit prüfen

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

Nature medicine, 2002-03, Vol.8 (3), p.282-288

2002

Link zum Volltext

Verfügbarkeit prüfen

Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine

Cell death & disease, 2022-11, Vol.13 (11), p.997-997, Article 997

2022

Link zum Volltext

Verfügbarkeit prüfen

Needling With 5-Fluorouracil (5-FU) After XEN Gel Stent Implantation: 6-Month Outcomes

Journal of glaucoma, 2018-10, Vol.27 (10), p.893-899

2018

Link zum Volltext

Verfügbarkeit prüfen

Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

Cell death & disease, 2021-07, Vol.12 (7), p.709-10, Article 709

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of Thiol Reactivity for Targeting Mutant p53

Cell chemical biology, 2018-10, Vol.25 (10), p.1219-1230.e3

2018

Link zum Volltext

Verfügbarkeit prüfen

Reactivation of Mutant p53 and Induction of Apoptosis in Human Tumor Cells by Maleimide Analogs

The Journal of biological chemistry, 2005-08, Vol.280 (34), p.30384-30391

2005

Link zum Volltext

Verfügbarkeit prüfen

A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death

EMBO molecular medicine, 2021-02, Vol.13 (2), p.e10852-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors

Frontiers in oncology, 2018-01, Vol.7, p.323-323

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant TP53 and PTEN

RNA biology, 2023, Vol.20 (1), p.368-383

2023

Link zum Volltext

Verfügbarkeit prüfen

Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death

Cell death & disease, 2017-06, Vol.8 (6), p.e2848-e2848

2017

Link zum Volltext

Verfügbarkeit prüfen

The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells

Translational oncology, 2018-12, Vol.11 (6), p.1343-1349

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

Cell death & disease, 2022-08, Vol.13 (8), p.672-672, Article 672

2022

Link zum Volltext

Verfügbarkeit prüfen

Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs

The Journal of biological chemistry, 2017-12, Vol.292 (48), p.19607-19607

2017

Link zum Volltext

Verfügbarkeit prüfen

Mutant p53 targeting by the low molecular weight compound STIMA‐1

Molecular oncology, 2017-05, Vol.11 (5), p.595-595

2017

Link zum Volltext

Verfügbarkeit prüfen

Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database

Carcinogenesis (New York), 2002-12, Vol.23 (12), p.2011-2018

2002

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249

Carcinogenesis (New York), 2008-07, Vol.29 (7), p.1428-1434

2008

Link zum Volltext

Verfügbarkeit prüfen

Optimization of application schedule of camphecene, a novel anti‐influenza compound, based on its pharmacokinetic characteristics

Fundamental & clinical pharmacology, 2022-06, Vol.36 (3), p.518-525

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(263)

Publikationsform

Sprache

Englisch
(239)
Russisch
(31)
Japanisch
(17)
Spanisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(71)
Physical Sciences
(65)
Humans
(51)
Medicin Och Hälsovetenskap
(51)
Technology
(46)
Engineering
(25)
Physics
(25)
Mutation
(23)
Oncology
(22)
Tumors
(22)
Biological And Medical Sciences
(20)
Male
(19)
Chemistry
(18)
Female
(18)
Biochemistry & Molecular Biology
(17)
Adult
(16)
Medical Sciences
(16)
Tumor Suppressor Protein P53 - Genetics
(16)
Animals
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Mutant p53 reactivation by small molecules makes its way to the clinic

APR-246 reactivates mutant p53 by targeting cysteines 124 and 277

Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy

Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene

The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer

Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246

PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine

Needling With 5-Fluorouracil (5-FU) After XEN Gel Stent Implantation: 6-Month Outcomes

Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

Role of Thiol Reactivity for Targeting Mutant p53

Reactivation of Mutant p53 and Induction of Apoptosis in Human Tumor Cells by Maleimide Analogs

A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death

Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors

Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant TP53 and PTEN

Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death

The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells

Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs

Mutant p53 targeting by the low molecular weight compound STIMA‐1

Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database

In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249

Optimization of application schedule of camphecene, a novel anti‐influenza compound, based on its pharmacokinetic characteristics

Suchergebnisse filtern